NQD
- Product code
- NQD
- Device name
- Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5270
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 19 (all years; only the last 3 years are listed here)
FDA classification definition
In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260026 | 2026-04-02 | Roche Diagnostics | Tina-quant Cardiac high sensitivity CRP III | |
| K233242 | 2024-01-18 | Siemens Healthcare Diagnostics, Inc. | Atellica® CH High Sensitivity C-Reactive Protein 2 (… |
Official FDA classification page: NQD
Classification and pathway per current FDA publications. Data from openFDA (CC0).